Miami, FL, January 16, 2019 --(PR.com
)-- Global OrthoBiologic, based in Miami, Florida, invests, identifies, develops and markets ground-breaking medical technologies related to Regenerative Medicine in the global market. Global OrthoBiologic is a privately-held medical technologies company specializing in therapies that significantly enhance the body’s natural healing ability. The company has developed extensive experience in the most advanced medical device industries. In the past several years, the emphasis has been focused exclusively on Regenerative Medicine and stem cell technologies, products, and therapies.
The technologies for stem cells are cutting edge, safe, clean and do not use any additives, enzymes, or require culturing or growing of cells. Global OrthoBiologic consults with medical technology companies that are startups and/or companies looking to expand and grow their business. Global OrthoBiologic has built a comprehensive network of experts in Europe, South America, Middle East, Asia, and Australia. The company partners with recognized medical facilities worldwide for evidence-based clinical medicine.
Global OrthoBiologic has announced today that it will expand its operation under the name Global REGENERATIVE Group (GRG) with headquarters to remain in Miami, Florida (globalregenerative.group) and will consist of 4 divisions, which will operate independently – Trade, Academy, Care and Finance. GRG will continue to offer its wide range of medical products in Regenerative Medicine in various fields of medicine through its Global REGENERATIVE Trade and will expand its operation with new technologies. Global REGENERATIVE Academy will concentrate on Medical Science and Education. Global REGENERATIVE Care will focus exclusively on Medical Tourism. Global REGENERATIVE Finance will identify medical advancements to improve patient outcome and speed patient recovery.
Mihail Blagoev, Vice President commented, “We are excited to continue our growth and understanding in the Regenerative Medicine Industry. Expanding our experience and dedication in medical science and education through positioned events on different continents will give an opportunity to more and more physicians and medical institutions to benefit from the Academy experts and to learn about the new advancements in Regenerative Medicine. I believe that our continued expansion will benefit our trading operation, and that will increase dramatically GRG revenue and value.”
Randy Beimel, President commented, “I would like to thank all of our partners that believed in us and our capabilities. All of you are significant proof for our success today to become one of the leaders in the Regenerative Medicine Industry. I would like to add that our Finance operation will be the key for our future success; we have seen many great ideas that stayed for years in the physician’s brains or at their ORs. We would like to identify these great medical ideas to first of all help the patients heal faster, and benefit GRG revenue and value.”